| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.19 | 6e-05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |